These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 20110009

  • 1. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N, McAfee AT, Koro C, Landon J, Arnold Chan K.
    Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
    [Abstract] [Full Text] [Related]

  • 2. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
    [Abstract] [Full Text] [Related]

  • 3. Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.
    Walker AM, Koro CE, Landon J.
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):760-8. PubMed ID: 18383443
    [Abstract] [Full Text] [Related]

  • 4. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC, Chen WL, Kao TW, Chang YW, Loh CH, Chou CC.
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [Abstract] [Full Text] [Related]

  • 5. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [Abstract] [Full Text] [Related]

  • 6. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.
    Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD.
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):504-12. PubMed ID: 17245800
    [Abstract] [Full Text] [Related]

  • 7. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.
    Stockl KM, Le L, Zhang S, Harada AS.
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):166-74. PubMed ID: 19109802
    [Abstract] [Full Text] [Related]

  • 8. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [Abstract] [Full Text] [Related]

  • 9. A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.
    Gerrits CM, Bhattacharya M, Manthena S, Baran R, Perez A, Kupfer S.
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1065-71. PubMed ID: 17674425
    [Abstract] [Full Text] [Related]

  • 10. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U, Pop-Busui R, Eagle KA.
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [Abstract] [Full Text] [Related]

  • 11. Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert.
    Hurren KM, Taylor TN, Jaber LA.
    Diabetes Res Clin Pract; 2011 Jul; 93(1):49-55. PubMed ID: 21440324
    [Abstract] [Full Text] [Related]

  • 12. Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy.
    Winkelmayer WC, Setoguchi S, Levin R, Solomon DH.
    Arch Intern Med; 2008 Nov 24; 168(21):2368-75. PubMed ID: 19029503
    [Abstract] [Full Text] [Related]

  • 13. Use of rosiglitazone and pioglitazone immediately after the cardiovascular risk warnings.
    Jain R, Mullins CD, Lee H, Wong W.
    Res Social Adm Pharm; 2012 Nov 24; 8(1):47-59. PubMed ID: 21733760
    [Abstract] [Full Text] [Related]

  • 14. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
    Lu CJ, Sun Y, Muo CH, Chen RC, Chen PC, Hsu CY.
    Cerebrovasc Dis; 2013 Nov 24; 36(2):145-51. PubMed ID: 24029780
    [Abstract] [Full Text] [Related]

  • 15. Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetes.
    Loebstein R, Dushinat M, Vesterman-Landes J, Silverman B, Friedman N, Katzir I, Kurnik D, Lomnicky Y, Kokia E, Halkin H.
    J Clin Pharmacol; 2011 Feb 24; 51(2):173-80. PubMed ID: 20484611
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.
    Starner CI, Schafer JA, Heaton AH, Gleason PP.
    J Manag Care Pharm; 2008 Feb 24; 14(6):523-31. PubMed ID: 18693776
    [Abstract] [Full Text] [Related]

  • 17. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A.
    Clin Ther; 2004 Dec 24; 26(12):2066-75. PubMed ID: 15823770
    [Abstract] [Full Text] [Related]

  • 18. Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials.
    Nagajothi N, Adigopula S, Balamuthusamy S, Velazquez-Cecena JL, Raghunathan K, Khraisat A, Singh S, Molnar J, Khosla S, Benatar D.
    Am J Ther; 2008 Dec 24; 15(6):506-11. PubMed ID: 19127132
    [Abstract] [Full Text] [Related]

  • 19. Thiazolidinediones and fractures in men and women.
    Dormuth CR, Carney G, Carleton B, Bassett K, Wright JM.
    Arch Intern Med; 2009 Aug 10; 169(15):1395-402. PubMed ID: 19667303
    [Abstract] [Full Text] [Related]

  • 20. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
    Rascati KL, Richards KM, Lopez D, Cheng LI, Wilson JP.
    Clin Ther; 2011 Dec 10; 33(12):2016-20. PubMed ID: 22101160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.